R

Recursion Pharmaceuticals
D

RXRX

6.02500
USD
0.33
(5.79%)
Market Open
Volume
296,712
EPS
0
Div Yield
-
P/E
-4
Market Cap
2,352,114,475
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    C
    CRIS
    -0.04000
    (-1.00%)
    3.96000 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    461.06 USD
    More
News

Title: Recursion Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.